Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1206963110 | 12069631 | 10 | F | 20140725 | 20160719 | 20160211 | 20160721 | EXP | CA-ROCHE-1405402 | ROCHE | 41.53 | YR | M | Y | 60.50000 | KG | 20160721 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1206963110 | 12069631 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N3676B01,N3667B01,N3693,N3699,N3734 | 125085 | 450 | MG | ||||||||
1206963110 | 12069631 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N3676B01,N3667B01,N3693,N3699,N3734 | 125085 | 420 | MG | QOW | |||||||
1206963110 | 12069631 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N3676B01,N3667B01,N3693,N3699,N3734 | 125085 | 510 | MG | Q3W | |||||||
1206963110 | 12069631 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N3676B01,N3667B01,N3693,N3699,N3734 | 125085 | 503 | MG | INFUSION | /wk | ||||||
1206963110 | 12069631 | 5 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N3676B01,N3667B01,N3693,N3699,N3734 | 125085 | 488 | MG | INFUSION | /wk | ||||||
1206963110 | 12069631 | 6 | SS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | U | 0 | 50 | MG | ||||||||
1206963110 | 12069631 | 7 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | U | 0 | 100 | MG | ||||||||
1206963110 | 12069631 | 8 | C | KEPPRA | LEVETIRACETAM | 1 | 0 | ||||||||||||
1206963110 | 12069631 | 9 | C | DECADRON | DEXAMETHASONE | 1 | 0 | ||||||||||||
1206963110 | 12069631 | 10 | C | PROCHLORAZINE | 2 | 0 | |||||||||||||
1206963110 | 12069631 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
1206963110 | 12069631 | 12 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1206963110 | 12069631 | 1 | Glioblastoma |
1206963110 | 12069631 | 6 | Product used for unknown indication |
1206963110 | 12069631 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1206963110 | 12069631 | OT |
1206963110 | 12069631 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1206963110 | 12069631 | Abdominal pain | |
1206963110 | 12069631 | Alanine aminotransferase increased | |
1206963110 | 12069631 | Aspartate aminotransferase increased | |
1206963110 | 12069631 | Bilirubin conjugated increased | |
1206963110 | 12069631 | Blood albumin decreased | |
1206963110 | 12069631 | Blood alkaline phosphatase increased | |
1206963110 | 12069631 | Blood bilirubin increased | |
1206963110 | 12069631 | Blood chloride increased | |
1206963110 | 12069631 | Blood creatinine decreased | |
1206963110 | 12069631 | Blood glucose increased | |
1206963110 | 12069631 | Blood lactate dehydrogenase increased | |
1206963110 | 12069631 | Blood pressure increased | |
1206963110 | 12069631 | Blood sodium increased | |
1206963110 | 12069631 | Blood testosterone decreased | |
1206963110 | 12069631 | Blood urea increased | |
1206963110 | 12069631 | Carcinoembryonic antigen increased | |
1206963110 | 12069631 | Constipation | |
1206963110 | 12069631 | Decreased appetite | |
1206963110 | 12069631 | Dizziness | |
1206963110 | 12069631 | Dyskinesia | |
1206963110 | 12069631 | Fatigue | |
1206963110 | 12069631 | Gait disturbance | |
1206963110 | 12069631 | Grip strength decreased | |
1206963110 | 12069631 | Haematocrit decreased | |
1206963110 | 12069631 | Haemoglobin decreased | |
1206963110 | 12069631 | Heart rate decreased | |
1206963110 | 12069631 | Hepatic enzyme increased | |
1206963110 | 12069631 | Hyperglycaemia | |
1206963110 | 12069631 | Hypoaesthesia | |
1206963110 | 12069631 | Immobile | |
1206963110 | 12069631 | Increased upper airway secretion | |
1206963110 | 12069631 | Lipase increased | |
1206963110 | 12069631 | Lymphocyte count decreased | |
1206963110 | 12069631 | Mean cell haemoglobin increased | |
1206963110 | 12069631 | Mean cell volume increased | |
1206963110 | 12069631 | Medication error | |
1206963110 | 12069631 | Micturition urgency | |
1206963110 | 12069631 | Mobility decreased | |
1206963110 | 12069631 | Movement disorder | |
1206963110 | 12069631 | Nasopharyngitis | |
1206963110 | 12069631 | Nausea | |
1206963110 | 12069631 | Neutrophil count increased | |
1206963110 | 12069631 | Platelet count decreased | |
1206963110 | 12069631 | Pulpitis dental | |
1206963110 | 12069631 | Red blood cell count decreased | |
1206963110 | 12069631 | Red cell distribution width increased | |
1206963110 | 12069631 | Somnolence | |
1206963110 | 12069631 | Tooth abscess | |
1206963110 | 12069631 | Viral infection | |
1206963110 | 12069631 | Vomiting | |
1206963110 | 12069631 | Weight decreased | |
1206963110 | 12069631 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1206963110 | 12069631 | 1 | 20140509 | 20160427 | 0 | |
1206963110 | 12069631 | 2 | 20140711 | 0 | ||
1206963110 | 12069631 | 3 | 20141219 | 0 | ||
1206963110 | 12069631 | 4 | 20150501 | 0 | ||
1206963110 | 12069631 | 5 | 20150925 | 0 | ||
1206963110 | 12069631 | 6 | 20140509 | 20141017 | 0 | |
1206963110 | 12069631 | 7 | 20140509 | 0 | ||
1206963110 | 12069631 | 11 | 20140509 | 20141017 | 0 |